His research interests have been focussed around lipoproteins, especially HDL. In addition to the basic research approach, prof. Savolainen has been principal investigator of many clinical trials involving patients with overweight, obesity, type 2 diabetes, hyperlipidaemia and other risk factors of coronary heart disease. To date, he has published more than 200 research papers in international peer-reviewed journals.